OSR Health, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-27.1M | $-2.4M | $403.8K | $-35.4K | $-3.3K |
| Depreciation & Amortization | — | — | — | — | — |
| Depreciation | $7.3K | $5.9K | — | — | — |
| Amortization | $9.3M | $9.6M | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Net Cash from Operating Activities | $-4.3M | $-1.8M | $-818.8K | $-4.2K | $-461 |
| Investing Activities | |||||
| Capital Expenditures | — | — | — | — | — |
| Business Acquisitions | $-1.2M | — | — | — | — |
| Net Cash from Investing Activities | $-2.6M | $503.6K | $-33.8M | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | $36.2M | $36.0M | — | — |
| Net Cash from Financing Activities | $8.4M | $1.2M | $34.5M | $124.0K | $-57.4K |
| Net Change in Cash | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |